PER percheron therapeutics limited

Ann: ATL1102 Data presented at MDA Annual Conference, page-9

  1. 14,802 Posts.
    lightbulb Created with Sketch. 1594
    Poor bone health with related morbidity is a major problem with Duchene Muscular Dystrophy (DMD). Decreased mobility and long-term corticosteroid therapy are involved in poor bone health in DMD. We investigated bone mineral density and bone metabolism in 30 steroid treated DMD patients and also compared mentioned factors between ambulated and non-ambulated patients.

    Read the full research article and you will find why I’m so excited
    Last edited by itsagas: 04/03/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $8.6K 910K

Buyers (Bids)

No. Vol. Price($)
2 499999 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 8734157 12
View Market Depth
Last trade - 16.10pm 01/08/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.